Tandem beats single ASCT for childhood neuroblastoma
CHICAGO – More children treated for high-risk neuroblastoma who received a second autologous stem cell transplant in consolidation after induction chemotherapy were alive after 3 years compared with...
Source: Clinical Neurology News - Category: Neurology Source Type: news
More News: Brain | Chemotherapy | Children | Neuroblastoma | Neurology | Stem Cell Therapy | Stem Cells | Transplants